User profiles for Stephane Jouneau
 | Stéphane JouneauMédecin Verified email at chu-rennes.fr Cited by 11362 |
Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis …
…, JF Viallard, F Maurier, S Jouneau… - Arthritis & …, 2013 - Wiley Online Library
Objective Earlier studies of eosinophilic granulomatosis with polyangiitis (Churg‐Strauss) (EGPA),
with limited patient numbers and followup durations, demonstrated that clinical …
with limited patient numbers and followup durations, demonstrated that clinical …
Comparison of long-term outcome between anti-Jo1-and anti-PL7/PL12 positive patients with antisynthetase syndrome
…, E Diot, C Landron, P Roblot, S Jouneau… - Autoimmunity …, 2012 - Elsevier
The aims of the present study were to: compare the characteristics between antisynthetase
syndrome (ASS) patients with anti-Jo1 antibody and those with anti-PL7/PL12 antibody. The …
syndrome (ASS) patients with anti-Jo1 antibody and those with anti-PL7/PL12 antibody. The …
Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients
P Fillatre, O Decaux, S Jouneau, M Revest… - The American journal of …, 2014 - Elsevier
Background Pneumocystis jiroveci pneumonia in human immunodeficiency virus (HIV)-negative
immunocompromised patients is associated with high mortality rates. Although …
immunocompromised patients is associated with high mortality rates. Although …
[HTML][HTML] Chest CT in COVID-19 pneumonia: A review of current knowledge
…, T Morcet-Delattre, F Ribet, S Jouneau… - Diagnostic and …, 2020 - Elsevier
The current COVID-19 pandemic has highlighted the essential role of chest computed
tomography (CT) examination in patient triage in the emergency departments, allowing them to be …
tomography (CT) examination in patient triage in the emergency departments, allowing them to be …
Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS
…, A Tissot, M Kerjouan, S Jouneau… - European …, 2018 - Eur Respiratory Soc
Exaggerated release of neutrophil extracellular traps (NETs) along with decreased NET
clearance and inability to remove apoptotic cells (efferocytosis) may contribute to sustained …
clearance and inability to remove apoptotic cells (efferocytosis) may contribute to sustained …
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase …
Background The use of cyclophosphamide in patients with acute exacerbation of idiopathic
pulmonary fibrosis (IPF) is unknown. Our study was designed to evaluate the efficacy and …
pulmonary fibrosis (IPF) is unknown. Our study was designed to evaluate the efficacy and …
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
…, V Jounieaux, N Roche, S Jouneau… - The Lancet …, 2020 - thelancet.com
Background Lung cancer screening with low-dose chest CT (LDCT) reduces the mortality of
eligible individuals. Blood signatures might act as a standalone screening tool, refine the …
eligible individuals. Blood signatures might act as a standalone screening tool, refine the …
Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: perspectives for scleroderma-associated interstitial lung …
…, C Morzadec, A Ballerie, S Jouneau… - Biochemical …, 2020 - Elsevier
Janus kinase (JAK) inhibitors (also termed Jakinibs) constitute a family of small drugs that
target various isoforms of JAKs (JAK1, JAK2, JAK3 and/or tyrosine kinase 2 (Tyk2)). They exert …
target various isoforms of JAKs (JAK1, JAK2, JAK3 and/or tyrosine kinase 2 (Tyk2)). They exert …
Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study
…, S Belaz, M Revest, P Tattevin, S Jouneau… - Journal of clinical …, 2014 - Am Soc Microbiol
Pneumocystis jirovecii pneumonia (PCP) is a life-threatening infection in immunocompromised
patients. Quantitative real-time PCR (qPCR) is more sensitive than microscopic …
patients. Quantitative real-time PCR (qPCR) is more sensitive than microscopic …
Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis
…, C Picard, MR Gaubert, S Jouneau… - European …, 2016 - Eur Respiratory Soc
Telomerase reverse transcriptase (TERT) or telomerase RNA (TERC) gene mutation is a
major monogenic cause of pulmonary fibrosis. Sequencing of TERT/TERC genes is proposed …
major monogenic cause of pulmonary fibrosis. Sequencing of TERT/TERC genes is proposed …